Imaging and image analysis solutions provider Genetix of
New Milton, UK, has received US patent No. 7,776,584, aspects of which have been
incorporated into the company’s ClonePix FL, a system used for screening and
selection of cell lines producing biopharmaceuticals. Significantly reducing the
time and cost associated with recombinant protein generation, the system has been
validated for the specific detection of secreted antibodies as well as monomeric,
cell surface and intrinsic GFP fusion proteins.
MORE FROM PHOTONICS MEDIA